The Procter & Gamble Company Tax Adjustments, Settlements, and Unusual Provisions
The Procter & Gamble Company (PG) reported Tax Adjustments, Settlements, and Unusual Provisions of $121.00 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-04-24.
Financial Statements › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2026-04-24
- The Procter & Gamble Company tax adjustments, settlements, and unusual provisions for the quarter ending 2026-03-31 was -$3.00M.
- The Procter & Gamble Company tax adjustments, settlements, and unusual provisions for the quarter ending 2025-12-31 was -$8.00M.
- The Procter & Gamble Company tax adjustments, settlements, and unusual provisions for the quarter ending 2025-09-30 was $132.00M.
- The Procter & Gamble Company tax adjustments, settlements, and unusual provisions for the quarter ending 2025-06-30 was $64.00M.
- The Procter & Gamble Company tax adjustments, settlements, and unusual provisions for fiscal 2025 was $114.00M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-24 | -$11.00M derived: sum of 2 quarters · filed 2026-04-24 | $121.00M 10-Q · filed 2026-04-24 | $185.00M derived: sum of 4 quarters · filed 2026-04-24 |
| 2025-12-31 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-23 | $124.00M 10-Q · filed 2026-01-23 | $188.00M derived: sum of 3 quarters · filed 2026-01-23 | |
| 2025-09-30 | $132.00M 10-Q · filed 2025-10-24 | $196.00M derived: sum of 2 quarters · filed 2025-10-24 | ||
| 2025-06-30 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-04 | $114.00M 10-K · filed 2025-08-04 | ||
| 2025-03-31 | $50.00M 10-Q · filed 2025-04-24 | |||
| 2024-03-31 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-19 | $90.00M 10-Q · filed 2024-04-19 | ||
| 2023-12-31 | $15.00M 10-Q · filed 2024-01-23 | |||
| 2023-03-31 | -$110.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-21 | $18.00M derived: sum of 2 quarters · filed 2023-04-21 | $30.00M 10-Q · filed 2023-04-21 | |
| 2022-12-31 | $128.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-19 | $140.00M 10-Q · filed 2023-01-19 | ||
| 2022-09-30 | $12.00M 10-Q · filed 2022-10-19 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-20 | $10.00M 10-Q · filed 2022-04-20 | ||
| 2021-12-31 | $10.00M 10-Q · filed 2022-01-19 | |||
| 2011-03-31 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-04-29 | $424.00M 10-Q · filed 2011-04-29 | ||
| 2010-12-31 | $380.00M 10-Q · filed 2011-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |